Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/1a/22/e9/1a22e915-616e-29da-7a1f-72e8635243ce/mza_5451444155506266709.jpg/600x600bb.jpg
Citeline Podcasts
Citeline
500 episodes
2 weeks ago
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻——再生元夹在成功与专利到期之间;第三季度十大畅销药物;礼来Retatrutide重塑减重标准;辉瑞坚守疫苗投资;赛诺菲在托布替尼困境中仍保持乐观。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/ Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX
Show more...
Business
RSS
All content for Citeline Podcasts is the property of Citeline and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻——再生元夹在成功与专利到期之间;第三季度十大畅销药物;礼来Retatrutide重塑减重标准;辉瑞坚守疫苗投资;赛诺菲在托布替尼困境中仍保持乐观。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/ Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX
Show more...
Business
https://i1.sndcdn.com/artworks-joC43iWrGpZxFnbz-29hSfQ-t3000x3000.png
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
Citeline Podcasts
14 minutes 37 seconds
2 weeks ago
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
Emma Wille and Summer Colling speak with ophthalmology expert, Joseph Jacob, to discuss the latest developments in dry age-related macular degeneration (dry AMD), including current treatments, emerging therapies, regulatory challenges, and the unmet needs shaping the future of patient care.
Citeline Podcasts
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻——再生元夹在成功与专利到期之间;第三季度十大畅销药物;礼来Retatrutide重塑减重标准;辉瑞坚守疫苗投资;赛诺菲在托布替尼困境中仍保持乐观。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/ Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX